Studies of genetics, serum cytokines, and autoimmune illnesses suggest that immune-related abnormalities are involved in the disease process of schizophrenia. Furthermore, direct evidence of cortical immune activation, including markedly elevated levels of many immune-related markers, have been reported in the prefrontal cortex in multiple cohorts of schizophrenia subjects. Within the prefrontal cortex in schizophrenia, deficits in the basilar dendritic spines of layer 3 pyramidal neurons and disturbances in inhibitory inputs to pyramidal neurons have also been commonly reported. Interestingly, microglia, the resident immune-related cells of the brain, also regulate excitatory and inhibitory input to pyramidal neurons. Consequently, in this review, we describe the cytological and molecular evidence of immune activation that has been reported in the brains of individuals with schizophrenia and the potential links between these immune-related disturbances with previously reported disturbances in pyramidal and inhibitory neurons in the disorder. Finally, we discuss the role that activated microglia may play in connecting these observations and as potential therapeutic treatment targets in schizophrenia.
Introduction
Multiple lines of evidence from biomarker, genetic and epidemiological studies have converged to indicate an important role of immune-related abnormalities in the disease process of schizophrenia (Horvath and Mirnics, 2014) . For example, higher levels of proinflammatory cytokines have been consistently reported in the peripheral serum of individuals with schizophrenia (Goldsmith et al., 2016; Miller et al., 2011; Potvin et al., 2008) . Furthermore, variants in immune-related genes that associate with a higher risk for schizophrenia have been identified across multiple, large scale genome-wide association studies (Purcell et al., 2009; Ripke et al., 2011; Shi et al., 2009; Stefansson et al., 2009 ). In addition, individuals with schizophrenia have a higher rate of autoimmune illnesses, and individuals with autoimmune illness have a higher frequency of psychotic symptoms (Benros et al., 2014a; Benros et al., 2014b) . Prenatal exposure to maternal immune activation, such as maternal exposure to infectious disease during pregnancy, is 
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